Ronald Muhlenkamp
Muhlenkamp & Co
Ronald Muhlenkamp Celanese Corp stake
total: 197
Muhlenkamp & Co CE trades
- Total transactions:
- 25
- New positions:
- 2
- Sold out:
- 1
- Added:
- 9
- Reduced:
- 13
- Held since:
- 2025 Q2
- Held for:
- 5 quarters
- Latest activity:
- 2026 Q2
According to 2026 Q2 report, Ronald Muhlenkamp holds 211,997 Celanese Corp (CE) shares with a market value of roughly $9.75M accounting for 2.82% of the overall portfolio. To date, the estimated cost basis is nearly $51.73 for "buy" trades. Muhlenkamp & Co first purchased CE in 2014 Q4, initially acquiring 268,235 shares. Ronald Muhlenkamp later completely sold out the position and invested in Celanese Corp again in 2025 Q2. Since the initial investment in Celanese Corp (CE), Muhlenkamp & Co has made 24 more transactions.
When did Ronald Muhlenkamp buy Celanese Corp (CE)?
Ronald Muhlenkamp first invested in Celanese Corp (CE) in 2014 Q4 at the reported quarter-end price of $59.96 per share.
What's the cost basis of Muhlenkamp & Co's CE stake?
The estimated cost basis for Celanese Corp (CE) stake is around $51.73 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $51.73
Ronald Muhlenkamp's historical trades in Celanese Corp
25 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2026 Q2
|
2.82%
|
211,997
|
$46.00
|
$9,751,862
|
+0.57% (+1,197)
|
+0.02%
|
|
2026 Q1
|
3.65%
|
210,800
|
$65.77
|
$13,864,316
|
+0.67% (+1,397)
|
+0.02%
|
|
2025 Q4
|
2.38%
|
209,403
|
$42.28
|
$8,853,559
|
+13.53% (+24,948)
|
+0.28%
|
|
2025 Q3
|
2.11%
|
184,455
|
$42.08
|
$7,761,884
|
+21.99% (+33,247)
|
+0.38%
|
|
2025 Q2
|
2.61%
|
151,208
|
$55.33
|
$8,366,322
|
new
|
+2.61%
|
|
2020 Q2
|
0.00%
|
$123.12
|
-100% (-49,326)
|
|||
|
2019 Q4
|
2.65%
|
$123.12
|
+0.13% (+63)
|
|||
|
2019 Q3
|
2.94%
|
$122.28
|
-0.03% (-15)
|
|||
|
2019 Q2
|
2.58%
|
$107.80
|
-50.10% (-49,483)
|
|||
|
2019 Q1
|
4.61%
|
$98.61
|
-1.91% (-1,925)
|
|||
|
2018 Q3
|
4.94%
|
$114.00
|
-0.58% (-591)
|
|||
|
2018 Q1
|
3.70%
|
$100.21
|
-7.83% (-8,603)
|
|||
|
2017 Q4
|
3.62%
|
$107.08
|
+0.50% (+545)
|
|||
|
2017 Q3
|
3.79%
|
$104.27
|
-10.50% (-12,830)
|
|||
|
2017 Q2
|
3.80%
|
$94.94
|
-0.13% (-155)
|
|||
|
2017 Q1
|
3.56%
|
$89.85
|
-0.24% (-300)
|
|||
|
2016 Q4
|
3.22%
|
$78.74
|
-0.89% (-1,100)
|
|||
|
2016 Q3
|
3.15%
|
$66.56
|
-0.68% (-850)
|
|||
|
2016 Q2
|
3.21%
|
$65.45
|
-0.56% (-700)
|
|||
|
2016 Q1
|
3.38%
|
$65.50
|
-53.35% (-143,265)
|
|||
|
2015 Q4
|
5.70%
|
$67.33
|
-0.01% (-35)
|
|||
|
2015 Q3
|
4.88%
|
$59.17
|
+0.04% (+110)
|
|||
|
2015 Q2
|
4.34%
|
$71.88
|
+0.07% (+175)
|
|||
|
2015 Q1
|
3.17%
|
$55.86
|
+0.02% (+50)
|
|||
|
2014 Q4
|
3.25%
|
$59.96
|
new
|
|||
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.